(LENZ) LENZ Therapeutics - Performance 65.7% in 12m
LENZ performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
44.72%
#10 in Peer-Group
Rel. Strength
89.12%
#808 in Stock-Universe
Total Return 12m
65.69%
#17 in Peer-Group
Total Return 5y
134.33%
#9 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 45.7 |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 37.37 USD |
| 52 Week Low | 17.29 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 36.54 |
| Buy/Sell Signal +-5 | -1.65 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: LENZ (65.7%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: LENZ vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for LENZ
| Total Return (including Dividends) | LENZ | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.51% | 2.09% | 4.55% |
| 3 Months | 14.00% | 2.27% | 10.78% |
| 12 Months | 65.69% | -10.84% | 14.71% |
| 5 Years | 134.33% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | LENZ | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 15.2% | 18.8% | 79.2% |
| 3 Months | 85.3% | 71.5% | 92.9% |
| 12 Months | 44.1% | -84.3% | 44.2% |
| 5 Years | 41.7% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th58.00 | -1.54% | -3.86% |
| 3 Month | %th64.00 | 11.48% | 2.91% |
| 12 Month | %th92.00 | 85.83% | 44.44% |
| 5 Years | %th97.00 | 291.17% | 52.90% |
FAQs
Does LENZ Therapeutics (LENZ) outperform the market?
Yes,
over the last 12 months LENZ made 65.69%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months LENZ made 14.00%, while XBI made 2.27%.
Performance Comparison LENZ vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
LENZ vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -6.8% | -4% | -4.5% | 51% |
| US NASDAQ 100 | QQQ | -7.6% | -5% | -6.7% | 51% |
| German DAX 40 | DAX | -6.6% | 0.5% | -17.5% | 36% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.5% | -3.7% | -2.5% | 48% |
| Hongkong Hang Seng | HSI | -6.4% | -5.3% | -20.3% | 30% |
| India NIFTY 50 | INDA | -6.4% | -1.6% | -4.3% | 66% |
| Brasil Bovespa | EWZ | -8.1% | -7.3% | -29% | 52% |
LENZ vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -8.3% | -6.3% | -11.2% | 37% |
| Consumer Discretionary | XLY | -5.2% | -1.1% | 4.2% | 46% |
| Consumer Staples | XLP | -3.3% | 2.1% | -2.7% | 57% |
| Energy | XLE | -2.4% | -3% | 0.9% | 70% |
| Financial | XLF | -6.9% | -2.6% | -7.6% | 37% |
| Health Care | XLV | -5.8% | -1.5% | 2.7% | 71% |
| Industrial | XLI | -6.4% | -3.2% | -11.1% | 42% |
| Materials | XLB | -4.8% | -1.1% | -3.9% | 63% |
| Real Estate | XLRE | -2.3% | 0.5% | -1.9% | 53% |
| Technology | XLK | -8.1% | -8.4% | -7.8% | 54% |
| Utilities | XLU | -4.4% | 0.5% | -7.9% | 41% |
| Aerospace & Defense | XAR | -8.7% | -9.4% | -25.9% | 13% |
| Biotech | XBI | -4.6% | -1.6% | 9.4% | 77% |
| Homebuilder | XHB | -5% | -5.6% | 6.7% | 65% |
| Retail | XRT | -3.7% | -0.9% | 4.2% | 60% |
LENZ vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.5% | -4.61% | 4.75% | 76% |
| Natural Gas | UNG | 5.4% | 9.9% | 10.6% | 73% |
| Gold | GLD | -1.8% | 2.7% | -24.4% | 24% |
| Silver | SLV | -3.4% | -3.4% | -23.1% | 43% |
| Copper | CPER | -7.1% | -3.7% | -24.2% | 50% |
LENZ vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -5.6% | -3.1% | -1.3% | 64% |
| iShares High Yield Corp. Bond | HYG | -4.7% | -1.4% | -3.5% | 55% |